

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.98278349 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.98278349 |
| 3 | signal peptide processing (GO:0006465) | 6.05961302 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.95637046 |
| 5 | protein retention in ER lumen (GO:0006621) | 5.39960060 |
| 6 | COPII vesicle coating (GO:0048208) | 4.96044927 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 4.41953748 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.41953748 |
| 9 | L-phenylalanine metabolic process (GO:0006558) | 4.31014986 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.31014986 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.19236837 |
| 12 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.19236837 |
| 13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.93333212 |
| 14 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.90470327 |
| 15 | positive regulation of nuclease activity (GO:0032075) | 3.83365177 |
| 16 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.79247502 |
| 17 | protein maturation by protein folding (GO:0022417) | 3.74037528 |
| 18 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.73071459 |
| 19 | negative regulation of interleukin-12 production (GO:0032695) | 3.72773087 |
| 20 | exocrine pancreas development (GO:0031017) | 3.69317586 |
| 21 | immunoglobulin mediated immune response (GO:0016064) | 3.63750371 |
| 22 | aromatic amino acid family catabolic process (GO:0009074) | 3.63694347 |
| 23 | regulation of nuclease activity (GO:0032069) | 3.59965288 |
| 24 | intestinal cholesterol absorption (GO:0030299) | 3.59257856 |
| 25 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.58241494 |
| 26 | cysteine metabolic process (GO:0006534) | 3.55640257 |
| 27 | sequestering of metal ion (GO:0051238) | 3.53803095 |
| 28 | 4-hydroxyproline metabolic process (GO:0019471) | 3.53540754 |
| 29 | cellular response to unfolded protein (GO:0034620) | 3.47866993 |
| 30 | protein carboxylation (GO:0018214) | 3.44706641 |
| 31 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.44706641 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 3.39922064 |
| 33 | neutrophil activation involved in immune response (GO:0002283) | 3.38627078 |
| 34 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.36389003 |
| 35 | cellular response to topologically incorrect protein (GO:0035967) | 3.34894954 |
| 36 | valine metabolic process (GO:0006573) | 3.34359224 |
| 37 | peptidyl-asparagine modification (GO:0018196) | 3.33219328 |
| 38 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.30049345 |
| 39 | ER-nucleus signaling pathway (GO:0006984) | 3.29499885 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.25971619 |
| 41 | tryptophan metabolic process (GO:0006568) | 3.22292444 |
| 42 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.17317268 |
| 43 | homocysteine metabolic process (GO:0050667) | 3.16005054 |
| 44 | B cell mediated immunity (GO:0019724) | 3.08965660 |
| 45 | protein N-linked glycosylation (GO:0006487) | 3.08437904 |
| 46 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.08126671 |
| 47 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.06727075 |
| 48 | tryptophan catabolic process (GO:0006569) | 3.05269001 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 3.05269001 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 3.05269001 |
| 51 | glyoxylate metabolic process (GO:0046487) | 3.03506551 |
| 52 | aldehyde catabolic process (GO:0046185) | 3.01852914 |
| 53 | vesicle coating (GO:0006901) | 3.01057267 |
| 54 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.99603823 |
| 55 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.97810412 |
| 56 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.95336636 |
| 57 | response to peptidoglycan (GO:0032494) | 2.94844599 |
| 58 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.93093405 |
| 59 | * response to endoplasmic reticulum stress (GO:0034976) | 2.92721409 |
| 60 | eosinophil chemotaxis (GO:0048245) | 2.92073358 |
| 61 | kynurenine metabolic process (GO:0070189) | 2.89758695 |
| 62 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.89568218 |
| 63 | serine family amino acid biosynthetic process (GO:0009070) | 2.89175981 |
| 64 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.87476391 |
| 65 | complement activation, classical pathway (GO:0006958) | 2.86171900 |
| 66 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.85296310 |
| 67 | lysine catabolic process (GO:0006554) | 2.85059175 |
| 68 | lysine metabolic process (GO:0006553) | 2.85059175 |
| 69 | cellular response to type I interferon (GO:0071357) | 2.84933332 |
| 70 | type I interferon signaling pathway (GO:0060337) | 2.84933332 |
| 71 | high-density lipoprotein particle remodeling (GO:0034375) | 2.82714308 |
| 72 | GDP-mannose metabolic process (GO:0019673) | 2.82154513 |
| 73 | DNA deamination (GO:0045006) | 2.80866010 |
| 74 | cytidine metabolic process (GO:0046087) | 2.80377528 |
| 75 | cytidine catabolic process (GO:0006216) | 2.80377528 |
| 76 | cytidine deamination (GO:0009972) | 2.80377528 |
| 77 | aromatic amino acid family metabolic process (GO:0009072) | 2.80310774 |
| 78 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.79672467 |
| 79 | peptide catabolic process (GO:0043171) | 2.79449880 |
| 80 | negative regulation of fibrinolysis (GO:0051918) | 2.78286292 |
| 81 | regulation of hypersensitivity (GO:0002883) | 2.77933223 |
| 82 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.77893204 |
| 83 | proline biosynthetic process (GO:0006561) | 2.77156784 |
| 84 | response to type I interferon (GO:0034340) | 2.75691852 |
| 85 | response to interferon-beta (GO:0035456) | 2.75466749 |
| 86 | bile acid biosynthetic process (GO:0006699) | 2.75064883 |
| 87 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.73607802 |
| 88 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.73481162 |
| 89 | tyrosine metabolic process (GO:0006570) | 2.71404328 |
| 90 | intestinal absorption (GO:0050892) | 2.70984988 |
| 91 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.70693474 |
| 92 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.70614796 |
| 93 | complement activation, alternative pathway (GO:0006957) | 2.70557623 |
| 94 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.68526591 |
| 95 | regulation of protein activation cascade (GO:2000257) | 2.67288839 |
| 96 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.66376963 |
| 97 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.66103549 |
| 98 | eosinophil migration (GO:0072677) | 2.65463235 |
| 99 | urea cycle (GO:0000050) | 2.64371115 |
| 100 | urea metabolic process (GO:0019627) | 2.64371115 |
| 101 | endocrine pancreas development (GO:0031018) | 2.64224755 |
| 102 | * response to unfolded protein (GO:0006986) | 2.64092794 |
| 103 | negative regulation of growth of symbiont in host (GO:0044130) | 2.63392092 |
| 104 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.63392092 |
| 105 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.63392092 |
| 106 | regulation of growth of symbiont in host (GO:0044126) | 2.63392092 |
| 107 | complement activation (GO:0006956) | 2.61471147 |
| 108 | alpha-linolenic acid metabolic process (GO:0036109) | 2.61334359 |
| 109 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.61325133 |
| 110 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.59920464 |
| 111 | protein autoprocessing (GO:0016540) | 2.59887903 |
| 112 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.59838582 |
| 113 | negative regulation of cell killing (GO:0031342) | 2.59838582 |
| 114 | cellular modified amino acid catabolic process (GO:0042219) | 2.59159871 |
| 115 | glycine metabolic process (GO:0006544) | 2.58951470 |
| 116 | * response to topologically incorrect protein (GO:0035966) | 2.58766440 |
| 117 | myeloid dendritic cell differentiation (GO:0043011) | 2.58433523 |
| 118 | neutrophil mediated immunity (GO:0002446) | 2.58259242 |
| 119 | reverse cholesterol transport (GO:0043691) | 2.57541852 |
| 120 | serine family amino acid metabolic process (GO:0009069) | 2.57140368 |
| 121 | myeloid dendritic cell activation (GO:0001773) | 2.56893148 |
| 122 | positive regulation of lymphocyte migration (GO:2000403) | 2.56397355 |
| 123 | cellular response to interferon-gamma (GO:0071346) | 2.56357129 |
| 124 | response to interferon-gamma (GO:0034341) | 2.56282607 |
| 125 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.55446938 |
| 126 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.55446938 |
| 127 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.55382540 |
| 128 | regulation of complement activation (GO:0030449) | 2.55206915 |
| 129 | regulation of fibrinolysis (GO:0051917) | 2.55039048 |
| 130 | protein-lipid complex remodeling (GO:0034368) | 2.54881612 |
| 131 | macromolecular complex remodeling (GO:0034367) | 2.54881612 |
| 132 | plasma lipoprotein particle remodeling (GO:0034369) | 2.54881612 |
| 133 | regulation of mononuclear cell migration (GO:0071675) | 2.54825237 |
| 134 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.53442496 |
| 135 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.53082420 |
| 136 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.53007005 |
| 137 | positive regulation of B cell differentiation (GO:0045579) | 2.52951001 |
| 138 | mitochondrial calcium ion transport (GO:0006851) | 2.52549145 |
| 139 | peptide hormone processing (GO:0016486) | 2.51502623 |
| 140 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.50776087 |
| 141 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.50681508 |
| 142 | tricarboxylic acid metabolic process (GO:0072350) | 2.49531398 |
| 143 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.49082274 |
| 144 | regulation of interleukin-1 secretion (GO:0050704) | 2.47049220 |
| 145 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.47008385 |
| 146 | positive regulation of B cell mediated immunity (GO:0002714) | 2.47008385 |
| 147 | indolalkylamine metabolic process (GO:0006586) | 2.46303000 |
| 148 | nitrogen cycle metabolic process (GO:0071941) | 2.46055711 |
| 149 | regulation of interferon-alpha production (GO:0032647) | 2.45577718 |
| 150 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.45569817 |
| 151 | nucleotide transmembrane transport (GO:1901679) | 2.45196546 |
| 152 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.45086975 |
| 153 | tetrahydrofolate metabolic process (GO:0046653) | 2.44504647 |
| 154 | granulocyte activation (GO:0036230) | 2.44394232 |
| 155 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.44332190 |
| 156 | benzene-containing compound metabolic process (GO:0042537) | 2.43660403 |
| 157 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.43597396 |
| 158 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.43324445 |
| 159 | branched-chain amino acid metabolic process (GO:0009081) | 2.42555905 |
| 160 | * cell redox homeostasis (GO:0045454) | 2.41792846 |
| 161 | regulation of chronic inflammatory response (GO:0002676) | 2.40416850 |
| 162 | regulation of triglyceride catabolic process (GO:0010896) | 2.39770522 |
| 163 | positive regulation of interleukin-10 production (GO:0032733) | 2.39704945 |
| 164 | T cell migration (GO:0072678) | 2.38025266 |
| 165 | regulation of T cell tolerance induction (GO:0002664) | 2.37925885 |
| 166 | proteasome assembly (GO:0043248) | 2.37480217 |
| 167 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.36677931 |
| 168 | neutrophil activation (GO:0042119) | 2.35759528 |
| 169 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.34451667 |
| 170 | angiotensin maturation (GO:0002003) | 2.34351221 |
| 171 | oligosaccharide catabolic process (GO:0009313) | 2.34133623 |
| 172 | glycosphingolipid catabolic process (GO:0046479) | 2.33342057 |
| 173 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.32913960 |
| 174 | glycolipid catabolic process (GO:0019377) | 2.32778291 |
| 175 | detection of other organism (GO:0098543) | 2.31270011 |
| 176 | actin nucleation (GO:0045010) | 2.29473697 |
| 177 | regulation of interleukin-12 production (GO:0032655) | 2.29435825 |
| 178 | myeloid leukocyte mediated immunity (GO:0002444) | 2.28868103 |
| 179 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.28546093 |
| 180 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.28277719 |
| 181 | regulation of lymphocyte migration (GO:2000401) | 2.27869315 |
| 182 | regulation of vitamin metabolic process (GO:0030656) | 2.27674250 |
| 183 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.27517645 |
| 184 | regulation of antigen processing and presentation (GO:0002577) | 2.27467040 |
| 185 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.26550439 |
| 186 | positive regulation of interferon-alpha production (GO:0032727) | 2.24914453 |
| 187 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.24700188 |
| 188 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.24557901 |
| 189 | detection of bacterium (GO:0016045) | 2.24469500 |
| 190 | lymphocyte chemotaxis (GO:0048247) | 2.24335043 |
| 191 | negative regulation of viral genome replication (GO:0045071) | 2.24324240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.35404124 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.89728022 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.74332494 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.56034608 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.44918060 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.18113780 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.15223931 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.90646737 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.69925694 |
| 10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.52169932 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.51536541 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.49429947 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.46407773 |
| 14 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.39643491 |
| 15 | GATA1_22025678_ChIP-Seq_K562_Human | 2.35593362 |
| 16 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.35523957 |
| 17 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.32654045 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.21896910 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.11894677 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.08673252 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.05448653 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.03759858 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.01254299 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.99161299 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.98531202 |
| 26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.90913667 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86372307 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.86289349 |
| 29 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.83818005 |
| 30 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.81885080 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.77593816 |
| 32 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.76363808 |
| 33 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.72822766 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.62687427 |
| 35 | GATA3_26560356_Chip-Seq_TH2_Human | 1.61723110 |
| 36 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.61641863 |
| 37 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.58853535 |
| 38 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58809717 |
| 39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55881663 |
| 40 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.53991037 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.53951338 |
| 42 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.52581343 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.52557940 |
| 44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.50924604 |
| 45 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.47908569 |
| 46 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.43602177 |
| 47 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.41096714 |
| 48 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.39095293 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38223544 |
| 50 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.35137653 |
| 51 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.33752742 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.33549565 |
| 53 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32900925 |
| 54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.32241638 |
| 55 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.31495600 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.30734034 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30598858 |
| 58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.29917325 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.29446794 |
| 60 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.27919967 |
| 61 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.27881647 |
| 62 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24706544 |
| 63 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.24399279 |
| 64 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.24379842 |
| 65 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.23747814 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.23551105 |
| 67 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.22215832 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21196956 |
| 69 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20522662 |
| 70 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.19612822 |
| 71 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.18950237 |
| 72 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.18107574 |
| 73 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.16012893 |
| 74 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.15807007 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15804833 |
| 76 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.15514068 |
| 77 | MYC_22102868_ChIP-Seq_BL_Human | 1.15435114 |
| 78 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15197993 |
| 79 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14728126 |
| 80 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13570243 |
| 81 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12407649 |
| 82 | MYB_26560356_Chip-Seq_TH2_Human | 1.09700828 |
| 83 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06765722 |
| 84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06244041 |
| 85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05871674 |
| 86 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.05389306 |
| 87 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.05060734 |
| 88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.04086117 |
| 89 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.03652039 |
| 90 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.03033567 |
| 91 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02630980 |
| 92 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01950936 |
| 93 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.01185681 |
| 94 | MYB_26560356_Chip-Seq_TH1_Human | 1.00305689 |
| 95 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99882282 |
| 96 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.99862908 |
| 97 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99329843 |
| 98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99158614 |
| 99 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.97695739 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96235645 |
| 101 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95417206 |
| 102 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94904738 |
| 103 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94185284 |
| 104 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.94104823 |
| 105 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93889669 |
| 106 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93834997 |
| 107 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.93200376 |
| 108 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.92890651 |
| 109 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91754160 |
| 110 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.91458527 |
| 111 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91442954 |
| 112 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91315474 |
| 113 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91040778 |
| 114 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.90714980 |
| 115 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.90654441 |
| 116 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.89586298 |
| 117 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.89298929 |
| 118 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89040312 |
| 119 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88930933 |
| 120 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.88561529 |
| 121 | AR_20517297_ChIP-Seq_VCAP_Human | 0.88523549 |
| 122 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.87724768 |
| 123 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.86160531 |
| 124 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85695144 |
| 125 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.85234609 |
| 126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85060173 |
| 127 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.84932597 |
| 128 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.84694975 |
| 129 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.84679468 |
| 130 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.83997792 |
| 131 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.83205735 |
| 132 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.81199989 |
| 133 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80842088 |
| 134 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.79811450 |
| 135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.79567732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.42174307 |
| 2 | MP0005360_urolithiasis | 3.77020203 |
| 3 | MP0005365_abnormal_bile_salt | 3.63687069 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 2.93126339 |
| 5 | MP0003195_calcinosis | 2.64228552 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.57436253 |
| 7 | MP0001666_abnormal_nutrient_absorption | 2.57271813 |
| 8 | MP0005220_abnormal_exocrine_pancreas | 2.40216633 |
| 9 | MP0005083_abnormal_biliary_tract | 2.32600306 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.25594029 |
| 11 | MP0003252_abnormal_bile_duct | 2.21225359 |
| 12 | MP0006054_spinal_hemorrhage | 2.14827295 |
| 13 | MP0008438_abnormal_cutaneous_collagen | 2.08757838 |
| 14 | MP0009840_abnormal_foam_cell | 2.04354796 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 1.96091395 |
| 16 | MP0001835_abnormal_antigen_presentation | 1.85116808 |
| 17 | MP0010329_abnormal_lipoprotein_level | 1.79976469 |
| 18 | MP0003436_decreased_susceptibility_to | 1.78245121 |
| 19 | MP0003300_gastrointestinal_ulcer | 1.76552934 |
| 20 | MP0005058_abnormal_lysosome_morphology | 1.75631815 |
| 21 | MP0005332_abnormal_amino_acid | 1.68753783 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.67766743 |
| 23 | MP0003186_abnormal_redox_activity | 1.66151612 |
| 24 | MP0009643_abnormal_urine_homeostasis | 1.65186210 |
| 25 | MP0002693_abnormal_pancreas_physiology | 1.64973784 |
| 26 | MP0003724_increased_susceptibility_to | 1.60088333 |
| 27 | MP0000609_abnormal_liver_physiology | 1.58600210 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.58465266 |
| 29 | MP0002006_tumorigenesis | 1.54493733 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.52666589 |
| 31 | MP0001944_abnormal_pancreas_morphology | 1.51201565 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.50532647 |
| 33 | MP0004264_abnormal_extraembryonic_tissu | 1.47609498 |
| 34 | MP0005319_abnormal_enzyme/_coenzyme | 1.39757597 |
| 35 | MP0000013_abnormal_adipose_tissue | 1.38404133 |
| 36 | MP0003868_abnormal_feces_composition | 1.37461104 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.34911705 |
| 38 | MP0003075_altered_response_to | 1.34558423 |
| 39 | MP0004043_abnormal_pH_regulation | 1.33536914 |
| 40 | MP0003448_altered_tumor_morphology | 1.33087532 |
| 41 | MP0002405_respiratory_system_inflammati | 1.28982287 |
| 42 | MP0000716_abnormal_immune_system | 1.28860574 |
| 43 | MP0008469_abnormal_protein_level | 1.26435526 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 1.25543699 |
| 45 | MP0009785_altered_susceptibility_to | 1.23369634 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.22780417 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.22165045 |
| 48 | MP0001790_abnormal_immune_system | 1.21629365 |
| 49 | MP0005387_immune_system_phenotype | 1.21629365 |
| 50 | MP0002118_abnormal_lipid_homeostasis | 1.19817504 |
| 51 | MP0001764_abnormal_homeostasis | 1.19426924 |
| 52 | MP0002166_altered_tumor_susceptibility | 1.17575643 |
| 53 | MP0000689_abnormal_spleen_morphology | 1.16953095 |
| 54 | MP0000685_abnormal_immune_system | 1.16350801 |
| 55 | MP0002398_abnormal_bone_marrow | 1.15169733 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.14820484 |
| 57 | MP0000343_altered_response_to | 1.14522846 |
| 58 | MP0002419_abnormal_innate_immunity | 1.14412301 |
| 59 | MP0000604_amyloidosis | 1.13884561 |
| 60 | MP0005025_abnormal_response_to | 1.13751939 |
| 61 | MP0004947_skin_inflammation | 1.13048726 |
| 62 | MP0005166_decreased_susceptibility_to | 1.12733547 |
| 63 | MP0005671_abnormal_response_to | 1.11578244 |
| 64 | MP0005164_abnormal_response_to | 1.10172381 |
| 65 | MP0009697_abnormal_copulation | 1.09857038 |
| 66 | MP0000598_abnormal_liver_morphology | 1.08476442 |
| 67 | MP0003656_abnormal_erythrocyte_physiolo | 1.08429107 |
| 68 | MP0001542_abnormal_bone_strength | 1.07846965 |
| 69 | MP0005275_abnormal_skin_tensile | 1.07399577 |
| 70 | MP0001800_abnormal_humoral_immune | 1.06982012 |
| 71 | MP0003045_fibrosis | 1.06479976 |
| 72 | MP0005408_hypopigmentation | 1.06430874 |
| 73 | MP0002254_reproductive_system_inflammat | 1.06012745 |
| 74 | MP0001873_stomach_inflammation | 1.05251452 |
| 75 | MP0002078_abnormal_glucose_homeostasis | 1.05011282 |
| 76 | MP0003693_abnormal_embryo_hatching | 1.04281864 |
| 77 | MP0002148_abnormal_hypersensitivity_rea | 1.03412615 |
| 78 | MP0002933_joint_inflammation | 1.02829688 |
| 79 | MP0002429_abnormal_blood_cell | 1.02204352 |
| 80 | MP0010234_abnormal_vibrissa_follicle | 1.01947114 |
| 81 | MP0001853_heart_inflammation | 1.00827752 |
| 82 | MP0009764_decreased_sensitivity_to | 1.00578893 |
| 83 | MP0005310_abnormal_salivary_gland | 1.00261790 |
| 84 | MP0002722_abnormal_immune_system | 0.99543909 |
| 85 | MP0002452_abnormal_antigen_presenting | 0.98834450 |
| 86 | MP0010386_abnormal_urinary_bladder | 0.98580553 |
| 87 | MP0008004_abnormal_stomach_pH | 0.98453883 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.98092696 |
| 89 | MP0006082_CNS_inflammation | 0.97277998 |
| 90 | MP0002723_abnormal_immune_serum | 0.96517385 |
| 91 | MP0010155_abnormal_intestine_physiology | 0.96050285 |
| 92 | MP0001756_abnormal_urination | 0.95502405 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 0.92400190 |
| 94 | MP0005464_abnormal_platelet_physiology | 0.92125134 |
| 95 | MP0005451_abnormal_body_composition | 0.90733541 |
| 96 | MP0004019_abnormal_vitamin_homeostasis | 0.90466808 |
| 97 | MP0003303_peritoneal_inflammation | 0.89630508 |
| 98 | MP0009384_cardiac_valve_regurgitation | 0.89214122 |
| 99 | MP0000858_altered_metastatic_potential | 0.89134866 |
| 100 | MP0009333_abnormal_splenocyte_physiolog | 0.87455846 |
| 101 | MP0005379_endocrine/exocrine_gland_phen | 0.85016713 |
| 102 | MP0002420_abnormal_adaptive_immunity | 0.85003988 |
| 103 | MP0009763_increased_sensitivity_to | 0.84947785 |
| 104 | MP0001819_abnormal_immune_cell | 0.83588168 |
| 105 | MP0002060_abnormal_skin_morphology | 0.83116778 |
| 106 | MP0003786_premature_aging | 0.82707240 |
| 107 | MP0003566_abnormal_cell_adhesion | 0.82113320 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.82050785 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.81515025 |
| 110 | MP0004883_abnormal_blood_vessel | 0.81407891 |
| 111 | MP0009642_abnormal_blood_homeostasis | 0.80577688 |
| 112 | MP0001545_abnormal_hematopoietic_system | 0.79954045 |
| 113 | MP0005397_hematopoietic_system_phenotyp | 0.79954045 |
| 114 | MP0003795_abnormal_bone_structure | 0.77605816 |
| 115 | MP0001765_abnormal_ion_homeostasis | 0.77566039 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.77230374 |
| 117 | MP0005165_increased_susceptibility_to | 0.77103797 |
| 118 | MP0002277_abnormal_respiratory_mucosa | 0.76684523 |
| 119 | MP0006036_abnormal_mitochondrial_physio | 0.76585857 |
| 120 | MP0002876_abnormal_thyroid_physiology | 0.75805210 |
| 121 | MP0002928_abnormal_bile_duct | 0.75428022 |
| 122 | MP0003763_abnormal_thymus_physiology | 0.73845835 |
| 123 | MP0005023_abnormal_wound_healing | 0.72922760 |
| 124 | MP0001243_abnormal_dermal_layer | 0.72609105 |
| 125 | MP0003172_abnormal_lysosome_physiology | 0.71642429 |
| 126 | MP0008873_increased_physiological_sensi | 0.70815829 |
| 127 | MP0003866_abnormal_defecation | 0.70559834 |
| 128 | MP0001191_abnormal_skin_condition | 0.67637892 |
| 129 | MP0000465_gastrointestinal_hemorrhage | 0.66559428 |
| 130 | MP0005376_homeostasis/metabolism_phenot | 0.65938439 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.63228831 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.76165068 |
| 2 | Hypoglycemic coma (HP:0001325) | 4.51254026 |
| 3 | Abnormality of the intrinsic pathway (HP:0010989) | 4.36899469 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.10114615 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.10114615 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.10114615 |
| 7 | Abnormality of the common coagulation pathway (HP:0010990) | 3.77495665 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.77293825 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 3.73122523 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.70366705 |
| 11 | Stomatitis (HP:0010280) | 3.57454071 |
| 12 | Prolonged partial thromboplastin time (HP:0003645) | 3.51241115 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 3.50704731 |
| 14 | Hypoglycemic seizures (HP:0002173) | 3.43586198 |
| 15 | Xanthomatosis (HP:0000991) | 3.41167994 |
| 16 | Deep venous thrombosis (HP:0002625) | 3.39483853 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.28765558 |
| 18 | Fat malabsorption (HP:0002630) | 3.22737007 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.20223961 |
| 20 | Retrobulbar optic neuritis (HP:0100654) | 3.14328823 |
| 21 | Optic neuritis (HP:0100653) | 3.14328823 |
| 22 | Generalized aminoaciduria (HP:0002909) | 3.07937516 |
| 23 | Orchitis (HP:0100796) | 3.01019451 |
| 24 | Hypoproteinemia (HP:0003075) | 3.00906447 |
| 25 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.99560666 |
| 26 | Ketoacidosis (HP:0001993) | 2.94814392 |
| 27 | Ketosis (HP:0001946) | 2.89803437 |
| 28 | Symptomatic seizures (HP:0011145) | 2.87734202 |
| 29 | Myositis (HP:0100614) | 2.87266407 |
| 30 | T lymphocytopenia (HP:0005403) | 2.81782411 |
| 31 | Dysostosis multiplex (HP:0000943) | 2.78013404 |
| 32 | Reduced antithrombin III activity (HP:0001976) | 2.77000812 |
| 33 | Steatorrhea (HP:0002570) | 2.76640191 |
| 34 | Mucopolysacchariduria (HP:0008155) | 2.73696688 |
| 35 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.73696688 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.71580419 |
| 37 | Abnormality of T cell number (HP:0011839) | 2.66037429 |
| 38 | Late onset (HP:0003584) | 2.60822312 |
| 39 | Complement deficiency (HP:0004431) | 2.60619578 |
| 40 | Chronic diarrhea (HP:0002028) | 2.58329553 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.57570700 |
| 42 | Conjugated hyperbilirubinemia (HP:0002908) | 2.53371367 |
| 43 | Methylmalonic acidemia (HP:0002912) | 2.50102507 |
| 44 | Beaking of vertebral bodies (HP:0004568) | 2.45253823 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.44270182 |
| 46 | Hypolipoproteinemia (HP:0010981) | 2.43895498 |
| 47 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.43843679 |
| 48 | Abnormal protein glycosylation (HP:0012346) | 2.42658666 |
| 49 | Abnormal glycosylation (HP:0012345) | 2.42658666 |
| 50 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.42658666 |
| 51 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.42658666 |
| 52 | Gout (HP:0001997) | 2.41872437 |
| 53 | Disinhibition (HP:0000734) | 2.41286277 |
| 54 | Pulmonary infiltrates (HP:0002113) | 2.38880199 |
| 55 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.38129242 |
| 56 | Hyperammonemia (HP:0001987) | 2.36857883 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.36395707 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.36395707 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.36395707 |
| 60 | Thrombocytosis (HP:0001894) | 2.35789083 |
| 61 | Abnormality of purine metabolism (HP:0004352) | 2.34601048 |
| 62 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.34086027 |
| 63 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.34086027 |
| 64 | Hyperlipoproteinemia (HP:0010980) | 2.33780498 |
| 65 | Nausea (HP:0002018) | 2.33277722 |
| 66 | Vasculitis (HP:0002633) | 2.33005928 |
| 67 | Keratoconjunctivitis sicca (HP:0001097) | 2.32912682 |
| 68 | 3-Methylglutaconic aciduria (HP:0003535) | 2.32305251 |
| 69 | Petechiae (HP:0000967) | 2.30259171 |
| 70 | Hyperglycemia (HP:0003074) | 2.29624576 |
| 71 | Joint hemorrhage (HP:0005261) | 2.28221664 |
| 72 | Pancreatitis (HP:0001733) | 2.27723910 |
| 73 | Chronic obstructive pulmonary disease (HP:0006510) | 2.26703398 |
| 74 | Obstructive lung disease (HP:0006536) | 2.26703398 |
| 75 | Gangrene (HP:0100758) | 2.26510109 |
| 76 | Methylmalonic aciduria (HP:0012120) | 2.26009432 |
| 77 | Acute hepatic failure (HP:0006554) | 2.25222696 |
| 78 | Hyperbilirubinemia (HP:0002904) | 2.23145279 |
| 79 | Recurrent skin infections (HP:0001581) | 2.22804300 |
| 80 | Loss of speech (HP:0002371) | 2.22751067 |
| 81 | Myocardial infarction (HP:0001658) | 2.22580136 |
| 82 | Hemoptysis (HP:0002105) | 2.22479778 |
| 83 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.21210795 |
| 84 | Keratoconjunctivitis (HP:0001096) | 2.20702405 |
| 85 | Amyloidosis (HP:0011034) | 2.20340465 |
| 86 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.19401512 |
| 87 | Eczematoid dermatitis (HP:0000976) | 2.18759949 |
| 88 | Progressive neurologic deterioration (HP:0002344) | 2.18741334 |
| 89 | Urticaria (HP:0001025) | 2.18317830 |
| 90 | Gingival bleeding (HP:0000225) | 2.18012983 |
| 91 | Mutism (HP:0002300) | 2.17670423 |
| 92 | Encephalitis (HP:0002383) | 2.17014736 |
| 93 | Hyperglycinemia (HP:0002154) | 2.16996469 |
| 94 | Abnormality of nucleobase metabolism (HP:0010932) | 2.15216321 |
| 95 | Abnormality of complement system (HP:0005339) | 2.14654545 |
| 96 | Recurrent cutaneous fungal infections (HP:0011370) | 2.13341828 |
| 97 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.13341828 |
| 98 | Nonimmune hydrops fetalis (HP:0001790) | 2.10144340 |
| 99 | Hyperglycinuria (HP:0003108) | 2.09998001 |
| 100 | Meningitis (HP:0001287) | 2.09452730 |
| 101 | Recurrent fungal infections (HP:0002841) | 2.09370287 |
| 102 | Mediastinal lymphadenopathy (HP:0100721) | 2.09203343 |
| 103 | Dicarboxylic aciduria (HP:0003215) | 2.09015291 |
| 104 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.09015291 |
| 105 | Gastrointestinal infarctions (HP:0005244) | 2.08282675 |
| 106 | Type I transferrin isoform profile (HP:0003642) | 2.08250067 |
| 107 | Recurrent viral infections (HP:0004429) | 2.08039569 |
| 108 | Abnormality of vitamin B metabolism (HP:0004340) | 2.07512222 |
| 109 | Abnormal cartilage morphology (HP:0002763) | 2.07329730 |
| 110 | Protuberant abdomen (HP:0001538) | 2.07164816 |
| 111 | Acute necrotizing encephalopathy (HP:0006965) | 2.07075360 |
| 112 | Abnormality of methionine metabolism (HP:0010901) | 2.06441210 |
| 113 | Systemic lupus erythematosus (HP:0002725) | 2.06105027 |
| 114 | Hepatosplenomegaly (HP:0001433) | 2.05939000 |
| 115 | Hematochezia (HP:0002573) | 2.05364984 |
| 116 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.04406197 |
| 117 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.04252708 |
| 118 | Autoimmune hemolytic anemia (HP:0001890) | 2.03919785 |
| 119 | IgG deficiency (HP:0004315) | 2.02916996 |
| 120 | Thoracolumbar scoliosis (HP:0002944) | 2.02561824 |
| 121 | Premature loss of primary teeth (HP:0006323) | 2.02442342 |
| 122 | Polyneuropathy (HP:0001271) | 2.01990803 |
| 123 | Anorexia (HP:0002039) | 2.00400376 |
| 124 | Poor head control (HP:0002421) | 1.99786869 |
| 125 | Increased serum ferritin (HP:0003281) | 1.99323626 |
| 126 | Abnormality of T cells (HP:0002843) | 1.99241188 |
| 127 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.98728129 |
| 128 | Abdominal distention (HP:0003270) | 1.97936311 |
| 129 | Increased IgM level (HP:0003496) | 1.97712843 |
| 130 | Epidermoid cyst (HP:0200040) | 1.97342905 |
| 131 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.95514937 |
| 132 | Joint swelling (HP:0001386) | 1.95370945 |
| 133 | Progressive macrocephaly (HP:0004481) | 1.95134720 |
| 134 | Degeneration of anterior horn cells (HP:0002398) | 1.94593532 |
| 135 | Abnormality of the anterior horn cell (HP:0006802) | 1.94593532 |
| 136 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93828982 |
| 137 | Abnormality of T cell physiology (HP:0011840) | 1.92903920 |
| 138 | Abnormality of glycine metabolism (HP:0010895) | 1.92712178 |
| 139 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.92712178 |
| 140 | Tongue fasciculations (HP:0001308) | 1.92098241 |
| 141 | Elevated alkaline phosphatase (HP:0003155) | 1.90965421 |
| 142 | Increased CSF lactate (HP:0002490) | 1.90925610 |
| 143 | Mitochondrial inheritance (HP:0001427) | 1.89253857 |
| 144 | Insulin resistance (HP:0000855) | 1.88245946 |
| 145 | Abnormality of urine glucose concentration (HP:0011016) | 1.88216353 |
| 146 | Glycosuria (HP:0003076) | 1.88216353 |
| 147 | Skin nodule (HP:0200036) | 1.87808621 |
| 148 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.87801581 |
| 149 | Cerebral hemorrhage (HP:0001342) | 1.87780238 |
| 150 | Mitral stenosis (HP:0001718) | 1.86907475 |
| 151 | Skin rash (HP:0000988) | 1.86676401 |
| 152 | Malnutrition (HP:0004395) | 1.86542952 |
| 153 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.86079689 |
| 154 | Proximal tubulopathy (HP:0000114) | 1.85694512 |
| 155 | Abnormal tarsal ossification (HP:0008369) | 1.80692755 |
| 156 | Metabolic acidosis (HP:0001942) | 1.80342399 |
| 157 | Menorrhagia (HP:0000132) | 1.79834677 |
| 158 | Vertebral compression fractures (HP:0002953) | 1.79511302 |
| 159 | Hypoalphalipoproteinemia (HP:0003233) | 1.78993610 |
| 160 | Glomerulonephritis (HP:0000099) | 1.78874104 |
| 161 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.76446868 |
| 162 | Cervical subluxation (HP:0003308) | 1.74398751 |
| 163 | Interstitial pulmonary disease (HP:0006530) | 1.71947023 |
| 164 | Opisthotonus (HP:0002179) | 1.71795368 |
| 165 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.70496150 |
| 166 | Vascular calcification (HP:0004934) | 1.69009285 |
| 167 | Lethargy (HP:0001254) | 1.68496775 |
| 168 | Multiple enchondromatosis (HP:0005701) | 1.67563761 |
| 169 | Recurrent bronchitis (HP:0002837) | 1.67457270 |
| 170 | Recurrent bacterial skin infections (HP:0005406) | 1.66999139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.35121963 |
| 2 | BCKDK | 3.81181460 |
| 3 | TAOK3 | 3.00559718 |
| 4 | MAP3K12 | 2.65770336 |
| 5 | RIPK4 | 2.65524839 |
| 6 | FLT3 | 2.59364715 |
| 7 | EIF2AK3 | 2.53367745 |
| 8 | IRAK3 | 2.45989924 |
| 9 | FRK | 2.37785779 |
| 10 | SIK3 | 2.36525496 |
| 11 | NME2 | 2.35963465 |
| 12 | BMPR2 | 2.31442208 |
| 13 | PASK | 2.21132546 |
| 14 | EIF2AK1 | 2.14588289 |
| 15 | INSRR | 2.12918821 |
| 16 | TRIM28 | 2.00653097 |
| 17 | TRIB3 | 1.97489953 |
| 18 | TBK1 | 1.80469409 |
| 19 | MAP4K1 | 1.79616547 |
| 20 | SCYL2 | 1.77109020 |
| 21 | PIM2 | 1.75826139 |
| 22 | ACVR1B | 1.75120302 |
| 23 | NEK9 | 1.70659595 |
| 24 | TYK2 | 1.68076536 |
| 25 | MAP3K3 | 1.67262957 |
| 26 | MST4 | 1.62924537 |
| 27 | GRK7 | 1.62402651 |
| 28 | FGFR4 | 1.60635050 |
| 29 | JAK3 | 1.56540165 |
| 30 | MAP4K2 | 1.55441528 |
| 31 | SIK1 | 1.55357476 |
| 32 | PDK2 | 1.55027881 |
| 33 | ZAP70 | 1.54328691 |
| 34 | PIK3CG | 1.50107390 |
| 35 | ERBB3 | 1.45642802 |
| 36 | PKN2 | 1.38044245 |
| 37 | BCR | 1.37188436 |
| 38 | BLK | 1.35009373 |
| 39 | MATK | 1.32179785 |
| 40 | TEC | 1.29475702 |
| 41 | KDR | 1.27155440 |
| 42 | TESK1 | 1.26888362 |
| 43 | MAP3K14 | 1.26785649 |
| 44 | RPS6KA4 | 1.26006225 |
| 45 | IRAK4 | 1.18778136 |
| 46 | EPHA3 | 1.14825287 |
| 47 | CDK19 | 1.11655335 |
| 48 | PTK6 | 1.11512058 |
| 49 | STK16 | 1.11350311 |
| 50 | BRSK2 | 1.07783336 |
| 51 | MAPKAPK3 | 1.07740473 |
| 52 | KIT | 1.05211402 |
| 53 | OXSR1 | 1.05185248 |
| 54 | PBK | 1.04447994 |
| 55 | BTK | 1.01989887 |
| 56 | LRRK2 | 0.98457266 |
| 57 | IKBKE | 0.98242407 |
| 58 | MAPK15 | 0.97733675 |
| 59 | LATS1 | 0.96825668 |
| 60 | TESK2 | 0.96486234 |
| 61 | NLK | 0.95615277 |
| 62 | JAK1 | 0.93687267 |
| 63 | STK10 | 0.93213960 |
| 64 | MAP2K3 | 0.92190895 |
| 65 | ADRBK2 | 0.89238993 |
| 66 | IRAK1 | 0.88077089 |
| 67 | TAOK2 | 0.86744713 |
| 68 | GRK1 | 0.86264780 |
| 69 | WNK3 | 0.86079842 |
| 70 | PAK4 | 0.82960468 |
| 71 | ITK | 0.82676098 |
| 72 | CSNK1G3 | 0.82309264 |
| 73 | HIPK2 | 0.80239981 |
| 74 | CSK | 0.74549015 |
| 75 | JAK2 | 0.74417237 |
| 76 | MAP3K2 | 0.73763176 |
| 77 | MAP2K2 | 0.72898160 |
| 78 | NUAK1 | 0.70220200 |
| 79 | STK24 | 0.69887317 |
| 80 | CSF1R | 0.69699250 |
| 81 | FGR | 0.69659287 |
| 82 | MST1R | 0.69555367 |
| 83 | CHUK | 0.69433771 |
| 84 | WNK4 | 0.68097338 |
| 85 | CLK1 | 0.67361721 |
| 86 | SYK | 0.67267669 |
| 87 | IKBKB | 0.66909848 |
| 88 | LYN | 0.65465529 |
| 89 | HCK | 0.64818714 |
| 90 | MAP3K11 | 0.63813883 |
| 91 | MET | 0.62926664 |
| 92 | MARK3 | 0.62612231 |
| 93 | BRAF | 0.62453075 |
| 94 | TRPM7 | 0.61866929 |
| 95 | NEK1 | 0.61594574 |
| 96 | CSNK1G2 | 0.61386125 |
| 97 | DYRK1B | 0.61323419 |
| 98 | LIMK1 | 0.59755942 |
| 99 | CSNK1G1 | 0.59685337 |
| 100 | TGFBR2 | 0.58705596 |
| 101 | TXK | 0.57873566 |
| 102 | ABL1 | 0.56694922 |
| 103 | YES1 | 0.56350194 |
| 104 | CSNK1A1L | 0.54755308 |
| 105 | ABL2 | 0.54038946 |
| 106 | MAP3K1 | 0.53136760 |
| 107 | PIM1 | 0.52949005 |
| 108 | PRKCI | 0.52695921 |
| 109 | CAMKK2 | 0.52318582 |
| 110 | ARAF | 0.52077964 |
| 111 | MAP3K10 | 0.51994454 |
| 112 | TGFBR1 | 0.49533675 |
| 113 | MAPK11 | 0.49105896 |
| 114 | EPHB1 | 0.48784491 |
| 115 | EIF2AK2 | 0.45703291 |
| 116 | RPS6KB2 | 0.45661506 |
| 117 | PRKCE | 0.44518238 |
| 118 | AKT3 | 0.43814134 |
| 119 | STK3 | 0.43103201 |
| 120 | MAP3K8 | 0.42578857 |
| 121 | LCK | 0.41559782 |
| 122 | BUB1 | 0.38347456 |
| 123 | FES | 0.38275640 |
| 124 | MOS | 0.37362727 |
| 125 | FER | 0.35610943 |
| 126 | EGFR | 0.35241262 |
| 127 | GRK6 | 0.35190961 |
| 128 | FGFR3 | 0.34050838 |
| 129 | MYLK | 0.33662719 |
| 130 | DYRK3 | 0.33070688 |
| 131 | RPS6KA5 | 0.32874542 |
| 132 | IGF1R | 0.32461754 |
| 133 | PTK2 | 0.31531416 |
| 134 | PDGFRA | 0.29130421 |
| 135 | MAP3K5 | 0.26619125 |
| 136 | PRKCQ | 0.26501347 |
| 137 | MAPKAPK2 | 0.25732164 |
| 138 | PRKCD | 0.24835436 |
| 139 | CSNK2A1 | 0.24281112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 4.69086919 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.83156988 |
| 3 | Asthma_Homo sapiens_hsa05310 | 2.80859653 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 2.80065380 |
| 5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.76527499 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.71950168 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.59444871 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.57894546 |
| 9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.45259620 |
| 10 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.44379173 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.38392424 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.28586551 |
| 13 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.06187370 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.03990110 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.99788727 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81492141 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.80697057 |
| 18 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.80050446 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.76304682 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.73268522 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.71555284 |
| 22 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.68232781 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.67068791 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.64247567 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.50368976 |
| 26 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.49242426 |
| 27 | Peroxisome_Homo sapiens_hsa04146 | 1.48038522 |
| 28 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.44933113 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.43783648 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.39934673 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33742935 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.33720536 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.33432451 |
| 34 | Phagosome_Homo sapiens_hsa04145 | 1.33146498 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.31631673 |
| 36 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.31562501 |
| 37 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.30198743 |
| 38 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.28697855 |
| 39 | Viral myocarditis_Homo sapiens_hsa05416 | 1.26293093 |
| 40 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.25297193 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.24596212 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22885797 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.22263243 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.19976810 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.19614018 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.15916905 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.15830056 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.15277103 |
| 49 | Salmonella infection_Homo sapiens_hsa05132 | 1.14992803 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.13761461 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.12469357 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.10230674 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.09861002 |
| 54 | Legionellosis_Homo sapiens_hsa05134 | 1.09244219 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08936065 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07792829 |
| 57 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.07548221 |
| 58 | Proteasome_Homo sapiens_hsa03050 | 1.06954677 |
| 59 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.02575951 |
| 60 | Malaria_Homo sapiens_hsa05144 | 1.00138122 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.99046165 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.98910336 |
| 63 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.98440725 |
| 64 | Shigellosis_Homo sapiens_hsa05131 | 0.97548400 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97200066 |
| 66 | Influenza A_Homo sapiens_hsa05164 | 0.96580102 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.94344425 |
| 68 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.93525305 |
| 69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.93068443 |
| 70 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92612257 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90790222 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.88782697 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.88418925 |
| 74 | Carbon metabolism_Homo sapiens_hsa01200 | 0.88025886 |
| 75 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87973987 |
| 76 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.86781569 |
| 77 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.86689999 |
| 78 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85854935 |
| 79 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.85124938 |
| 80 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.84513526 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.84472226 |
| 82 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.83872471 |
| 83 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.83085175 |
| 84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.83071157 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.82023327 |
| 86 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81571344 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80033902 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78721972 |
| 89 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.78252953 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.77433971 |
| 91 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.76504723 |
| 92 | Parkinsons disease_Homo sapiens_hsa05012 | 0.75132884 |
| 93 | Retinol metabolism_Homo sapiens_hsa00830 | 0.72682677 |
| 94 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68901596 |
| 95 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68736035 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.67459817 |
| 97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67395454 |
| 98 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64021373 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.62958694 |
| 100 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.62565636 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.61421361 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60202126 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58551519 |
| 104 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.57362366 |
| 105 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.56530982 |
| 106 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.56106292 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54940028 |
| 108 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53681662 |
| 109 | DNA replication_Homo sapiens_hsa03030 | 0.52658174 |
| 110 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52500857 |
| 111 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.52192503 |
| 112 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50832323 |
| 113 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.50508082 |
| 114 | Mineral absorption_Homo sapiens_hsa04978 | 0.50065718 |
| 115 | Leishmaniasis_Homo sapiens_hsa05140 | 0.49191237 |
| 116 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48550281 |
| 117 | Ribosome_Homo sapiens_hsa03010 | 0.48114135 |
| 118 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46534188 |
| 119 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.46278393 |
| 120 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.45539824 |
| 121 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.44863820 |
| 122 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.44389720 |
| 123 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43918763 |
| 124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41740180 |
| 125 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.40866967 |
| 126 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.39721668 |
| 127 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.39232611 |
| 128 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.39211978 |
| 129 | RNA degradation_Homo sapiens_hsa03018 | 0.38654002 |
| 130 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.38464923 |
| 131 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35806737 |
| 132 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35659763 |
| 133 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35264329 |
| 134 | Pertussis_Homo sapiens_hsa05133 | 0.35111870 |
| 135 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.34421928 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.32920447 |
| 137 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32320716 |
| 138 | Measles_Homo sapiens_hsa05162 | 0.31674015 |
| 139 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30797376 |
| 140 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.30551898 |
| 141 | Bile secretion_Homo sapiens_hsa04976 | 0.30003059 |

